Update on Pharmaceutical Intervention for Disorders of Consciousness and Agitation After Traumatic Brain Injury in Children

Research output: Contribution to journalArticlepeer-review

Abstract

Responsiveness and agitation are common targets for pharmaceutical intervention after traumatic brain injury (TBI) in children. This focused review presents a critical discussion of the limited literature available on the use of medications for disorders of consciousness and agitation in children with TBI. For disorders of consciousness, evidence from several small studies supports a potential benefit of dopaminergic agents for improving responsiveness in some children with lower levels of function after TBI. Larger studies, likely requiring multicenter collaborations, are needed to more definitively address questions regarding the use of medications for responsiveness in children with TBI. The literature regarding use of pharmaceutical agents for agitation in children with TBI is even more limited. The dearth of literature regarding the effects of medications used for agitation in children with TBI highlights the need for additional basic and clinical science contributions in this area.

Original languageEnglish (US)
Pages (from-to)142-147
Number of pages6
JournalPM and R
Volume5
Issue number2
DOIs
StatePublished - Feb 1 2013

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Update on Pharmaceutical Intervention for Disorders of Consciousness and Agitation After Traumatic Brain Injury in Children'. Together they form a unique fingerprint.

Cite this